Cara Therapeutics Reports Second Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/6/2026
- Mahindra & Mahindra Ltd (MM:IN) (MAHMF) PT Raised to INR320 at HSBC
- HSBC Downgrades Shriram Finance Ltd (SHFL:IN) to Hold
- UK budget airline easyJet ready to accept $7.3 billion takeover bid from Castlelake
- Strategy reports $8.32B bitcoin loss and sells BTC to fund dividends
- Citi Adds Micron Technology (MU) to 90-Day Upside Catalyst Watch List
Cara Therapeutics (CARA) Tops Q2 EPS by 18c
August 8, 2022 4:30 PM EDTCara Therapeutics (NASDAQ: CARA) reported Q2 EPS of ($0.08), $0.18 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $23 million versus the consensus estimate of $21.11 million.
For earnings history and earnings-related data on Cara Therapeutics (CARA) click here.
... More